Oppenheimer & Co’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Oppenheimer & Co's EXEL Position: Q1 2025 in Review
Oppenheimer & Co sold out of Exelixis (EXEL) in Q1 2025, closing a stake of 16,836 shares — an estimated $561K sold.
Oppenheimer & Co first reported a position in EXEL in Q1 2014 and held it in 22 quarters. The position peaked at $3M in Q3 2015. 557 funds tracked by Wall St. Rank hold EXEL as of Q1 2025.
- Oppenheimer & Co reported no remaining Exelixis position as of Q1 2025 after selling out during the quarter.
- Oppenheimer & Co sold 16,836 Exelixis shares in Q1 2025, an estimated $561K.
- Oppenheimer & Co first reported a position in Exelixis in Q1 2014 and held it in 22 quarters.
- Oppenheimer & Co's Exelixis position peaked at $3M in Q3 2015.
- 557 funds tracked by Wall St. Rank held Exelixis as of Q1 2025.
Based on Oppenheimer & Co's 13F filing for Q1 2025, filed 23 Apr 2025.